Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-28
DOI
10.3389/fimmu.2020.00040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NK cells specifically TCR-dressed to kill cancer cells
- (2019) Nadia Mensali et al. EBioMedicine
- Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
- (2019) Christopher D. Cluxton et al. PLoS One
- Nectin-2 in Ovarian Cancer: how is it expressed and what might be its functional role?
- (2019) Inga Bekes et al. CANCER SCIENCE
- Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer
- (2019) Ayhan Parlar et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
- (2018) Lucas Ferrari de Andrade et al. SCIENCE
- NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia
- (2018) Franco Locatelli et al. TRENDS IN IMMUNOLOGY
- Elevated Nectin-2 expression is involved in esophageal squamous cell carcinoma by promoting cell migration and invasion
- (2018) Ming Li et al. Oncology Letters
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- High-Risk Leukemia: Past, Present, and Future Role of NK Cells
- (2018) Melissa Mavers et al. Journal of Immunology Research
- NK cell education in tumor immune surveillance: DNAM-1/KIR receptor ratios as predictive biomarkers for solid tumor outcome.
- (2018) Concepción Fátima Guillamón et al. Cancer Immunology Research
- NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
- (2018) Dominik Schmiedel et al. Frontiers in Immunology
- Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
- (2017) Suzanne George et al. IMMUNITY
- Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells
- (2017) David H. Raulet et al. IMMUNOLOGICAL REVIEWS
- Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
- (2017) Rosa Molfetta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells
- (2017) Qianqian Zheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
- (2017) K H Chen et al. LEUKEMIA
- The prognostic value of PCNA expression in patients with osteosarcoma
- (2017) Xing Wang et al. MEDICINE
- Toil enables reproducible, open source, big biomedical data analyses
- (2017) John Vivian et al. NATURE BIOTECHNOLOGY
- Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas
- (2017) Michael J. Nathenson et al. ONCOLOGIST
- Managing sarcoma: where have we come from and where are we going?
- (2017) Jenna S. Bleloch et al. Therapeutic Advances in Medical Oncology
- Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
- (2017) Simin Kiany et al. OncoImmunology
- Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients
- (2016) Nayeli Goreti Nieto-Velázquez et al. Translational Oncology
- Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing
- (2016) Conor J. Kearney et al. OncoImmunology
- Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
- (2016) Sareetha Kailayangiri et al. OncoImmunology
- Increased Soluble CD155 in the Serum of Cancer Patients
- (2016) Akiko Iguchi-Manaka et al. PLoS One
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
- (2015) Gerharda H. Boerman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma
- (2015) M. Karabulut et al. Clinical & Translational Oncology
- The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas
- (2015) Shan Liang et al. DISEASE MARKERS
- DNAM-1 controls NK cell activation via an ITT-like motif
- (2015) Zhanguang Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15
- (2015) Ana M. Vuletić et al. MELANOMA RESEARCH
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
- (2015) Sabrina Genßler et al. OncoImmunology
- A Novel Method for Assessment of Natural Killer Cell Cytotoxicity Using Image Cytometry
- (2015) Srinivas S. Somanchi et al. PLoS One
- Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma
- (2015) Valentina Bevelacqua et al. Oncotarget
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma
- (2014) Xiaojun Huang et al. HUMAN PATHOLOGY
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
- (2014) Leticia Huergo-Zapico et al. PLoS One
- Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
- (2013) Ryuji Takahashi et al. CANCER SCIENCE
- Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody
- (2013) Ge Zhang et al. IMMUNOLOGY AND CELL BIOLOGY
- Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis
- (2013) Gang Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers
- (2013) Tsutomu Oshima et al. Molecular Cancer
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44
- (2013) Nathan C. Horton et al. PLoS One
- Prognostic significance of CD155 mRNA expression in soft tissue sarcomas
- (2013) SATORU ATSUMI et al. Oncology Letters
- SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
- (2012) Satoshi Kawaguchi et al. CANCER SCIENCE
- Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
- (2012) Tolga Sutlu et al. HUMAN GENE THERAPY
- Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection
- (2012) Manfred Lehner et al. PLoS One
- Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor
- (2011) Daniela Montagna et al. CYTOTHERAPY
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44
- (2011) B. Rosental et al. JOURNAL OF IMMUNOLOGY
- Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood
- (2011) Martin Lundberg et al. NUCLEIC ACIDS RESEARCH
- Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma
- (2010) Reiko Nakai et al. CANCER SCIENCE
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- Activating and inhibitory receptors of natural killer cells
- (2010) Hollie J Pegram et al. IMMUNOLOGY AND CELL BIOLOGY
- Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
- (2010) Lola Fernández-Messina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NKG2D Initiates Caspase-Mediated CD3 Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease
- (2010) N. Hanaoka et al. JOURNAL OF IMMUNOLOGY
- Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated
- (2010) M Meissner et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Natural Killer Cell Tolerance Persists Despite Significant Reduction of Self MHC Class I on Normal Target Cells in Mice
- (2010) Petter Brodin et al. PLoS One
- Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases
- (2009) B. M. Carreno et al. CLINICAL CANCER RESEARCH
- Safety analysis ofex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
- (2009) Lisbeth Barkholt et al. Immunotherapy
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
- (2009) Dagmar Berghuis et al. JOURNAL OF PATHOLOGY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
- (2008) Dirk H.J. Verhoeven et al. MOLECULAR IMMUNOLOGY
- A Multicolor Panel of Novel Lentiviral “Gene Ontology” (LeGO) Vectors for Functional Gene Analysis
- (2008) Kristoffer Weber et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started